These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 6023602)

  • 21. Behavioral effects of L-alpha-methyltyrosine, an inhibitor of tyrosine hydroxylase.
    Weissman A; Koe BK
    Life Sci; 1965 May; 4(10):1037-48. PubMed ID: 5838507
    [No Abstract]   [Full Text] [Related]  

  • 22. Histochemical fluorescence detection of changes in central monoamine neurones provoked by drugs acting on the CNS.
    Fuxe K; Hökfelt T
    Triangle; 1971; 10(3):73-84. PubMed ID: 5138525
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of neuroleptics on the activity of central catecholamine neurones.
    Corrodi H; Fuxe K; Hökfelt T
    Life Sci; 1967 Apr; 6(7):767-74. PubMed ID: 6031261
    [No Abstract]   [Full Text] [Related]  

  • 24. Modification by disulfiram or methyltyrosine methylester (H 44-68) of abstinence symptoms in morphine-tolerant rats.
    Mattila MJ; Alhava E; Mansner R
    Arzneimittelforschung; 1968 Sep; 18(9):1163-6. PubMed ID: 5755932
    [No Abstract]   [Full Text] [Related]  

  • 25. [On the mechanism of adrenergic action of alpha-methyl-m-tyrosine].
    Gessa GL; Vargiu L; Crabai E
    Boll Soc Ital Biol Sper; 1966 Apr; 42(7):359-61. PubMed ID: 5949373
    [No Abstract]   [Full Text] [Related]  

  • 26. Adrenal and brain catecholamine responses to acute and chronic morphine administration to rats, after inhibition of tyrosine hydroxylase and monoamine oxidase.
    Guaza C; Torrellas A; Borrell J; Borrell S
    Arch Farmacol Toxicol; 1983 Aug; 9(2):131-40. PubMed ID: 6140899
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of disulfiram on catecholamine levels in the brain.
    Goldstein M; Nakajima K
    J Pharmacol Exp Ther; 1967 Jul; 157(1):96-102. PubMed ID: 6029496
    [No Abstract]   [Full Text] [Related]  

  • 28. Modification of the effects of tranquilizers in animals treated with alpha-methyl-l-tryrosine.
    Menon MK; Dandiya PC; Bapna JS
    J Pharmacol Exp Ther; 1967 Apr; 156(1):63-9. PubMed ID: 6023601
    [No Abstract]   [Full Text] [Related]  

  • 29. The effects of barbiturates on the activity of the catecholamine neurones in the rat brain.
    Corrodi H; Fuxe K; Hökfelt T
    J Pharm Pharmacol; 1966 Aug; 18(8):556-8. PubMed ID: 4381869
    [No Abstract]   [Full Text] [Related]  

  • 30. In vivo inhibition of dopamine beta-hydroxylase by 1-phenyl-3-(2-thiazolyl)-2-thiourea (U-14,624).
    Johnson GA; Boukma SJ; Kim EG
    J Pharmacol Exp Ther; 1970 Jan; 171(1):80-7. PubMed ID: 5410940
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of brain norepinephrine in the anorexic effects of dextroamphetamine and monoamine oxidase inhibitors in the rat.
    Holtzman SG; Jewett RE
    Psychopharmacologia; 1971; 22(2):151-61. PubMed ID: 5124188
    [No Abstract]   [Full Text] [Related]  

  • 32. Cerebral dopamine and noradrenaline turnover and effects of morphine test dose in rats withdrawn from 20 days' morphine treatment.
    Attila LM; Ahtee L
    Med Biol; 1983; 61(5):249-257. PubMed ID: 6686987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced sensitivity to noradrenergic agonists and tolerance development to -methyltyrosine in the rat.
    Beuthin FC; Miya TS; Blake DE; Bousquet WF
    J Pharmacol Exp Ther; 1972 Jun; 181(3):446-56. PubMed ID: 5033011
    [No Abstract]   [Full Text] [Related]  

  • 34. Carbamazepine decreases catecholamine turnover in the rat brain.
    Waldmeier PC; Baumann PA; Fehr B; De Herdt P; Maitre L
    J Pharmacol Exp Ther; 1984 Oct; 231(1):166-72. PubMed ID: 6491972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of alpha-methyltyrosine on operant behavior and brain catecholamine levels.
    Schoenfeld RI; Seiden LS
    J Pharmacol Exp Ther; 1969 Jun; 167(2):319-27. PubMed ID: 5787869
    [No Abstract]   [Full Text] [Related]  

  • 36. Norepinephrine and dopamine in the developing chick brain.
    Kobayashi K; Eiduson S
    Dev Psychobiol; 1970; 3(1):13-34. PubMed ID: 4146802
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of dopamine in motor excitation of mice induced by brain catecholamine releasers.
    Graeff FG
    J Pharm Pharmacol; 1966 Sep; 18(9):627-8. PubMed ID: 4381952
    [No Abstract]   [Full Text] [Related]  

  • 38. Cerebral catecholamine depletion in mice withdrawn from repeated morphine treatment and development of tolerance to the enhancing effect of morphine on noradrenaline depletion.
    Etemadzadeh E
    J Pharmacol Exp Ther; 1993 Aug; 266(2):749-55. PubMed ID: 8355206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mescaline: its effects on learning rate and dopamine metabolism in goldfish (Carassius auratus).
    Zeller EA; Couper GS; Huprikar SV; Mellow AM; Moody RR
    Experientia; 1976 Nov; 32(11):1453-4. PubMed ID: 991995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of prostaglandins on catecholamine metabolism of the central nervous system in rats.
    Telegdy G
    Acta Physiol Acad Sci Hung; 1981; 57(3):221-4. PubMed ID: 6946681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.